lamivudine has been researched along with Hepatic Encephalopathy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzzetti, E; Davidson, BR; Gurusamy, KS; Mantzoukis, K; RodrÃguez-Perálvarez, M; Thorburn, D; Tsochatzis, E | 1 |
| Hanada, S; Harada, M; Kaji, R; Kumashiro, R; Sata, M | 1 |
| Bogaerts, V; Doutreloigne, J; Fan, ST; Hui, CK; Lai, CL; Li, TM; Sablon, E; Wong, BC; Wong, DK; Yuan, HJ; Yuen, MF | 1 |
| Cai, C; Chen, G; He, X; Huang, J; Lu, M; Wang, G; Yang, Y; Zhu, X | 1 |
| Changchien, CS; Lee, CM; Lu, SN; Tseng, PL; Tung, HD; Wang, JH | 1 |
| Su, GG; Ying, MF; Zhao, NF; Zhou, Y | 1 |
1 review(s) available for lamivudine and Hepatic Encephalopathy
| Article | Year |
|---|---|
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Topics: Acute Disease; Antiviral Agents; Disease Progression; Guanine; Hepatic Encephalopathy; Hepatitis B; Hepatitis C, Chronic; Humans; Immunization, Passive; Interferons; Lamivudine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2017 |
1 trial(s) available for lamivudine and Hepatic Encephalopathy
| Article | Year |
|---|---|
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Organophosphonates; Survival Analysis; Taiwan | 2005 |
4 other study(ies) available for lamivudine and Hepatic Encephalopathy
| Article | Year |
|---|---|
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
Topics: Antiviral Agents; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Recurrence | 2002 |
Prognostic factors in severe exacerbation of chronic hepatitis B.
Topics: Adolescent; Adult; Aged; Ascites; Biomarkers; DNA, Viral; Female; Fibrosis; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Prognosis; Promoter Regions, Genetic; Serologic Tests | 2003 |
Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China.
Topics: Adult; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate | 2002 |
[Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation].
Topics: Adenine; Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Female; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Organophosphonates; Protein Structure, Tertiary; Recurrence; Reverse Transcription | 2005 |